Renalytix PLC develops artificial intelligence-enabled clinical diagnostic solutions specifically for kidney disease. The company's primary product, kidneyintelX.dkd, aims to enhance patient outcomes through improved clinical management of kidney conditions. Renalytix operates in the healthcare sector, targeting healthcare providers and laboratories, primarily in the United States and Ireland, with a focus on expanding its commercial testing capabilities and reimbursement policies.